Marinomed Biotech AG

Major Shareholding Notification • Feb 5, 2019

Publication Date: 05.02.2019 17:34 EANS-Voting Rights: Marinomed Biotech AG / Publication of a participation notification according to art. 135 para. 2 Stock Exchange Act

Notification of voting rights transmitted by euro adhoc with the aim of a Europe-wide distribution. The issuer is responsible for the content of this announcement.

Major holdings notification pursuant to Sec. 130 to 134 BörseG 2018 Wien, 4.2.2019 Overview 1. Issuer: Marinomed Biotech AG 2. Reason for the notification: Other 3. Person subject to notification obligation Name: Republik Österreich City: Österreich Country: Österreich 4. Name of shareholder(s): aws Mittelstandsfonds Beteiligungs GmbH & Co KG 5. Date on which the threshold was crossed or reached: 1.2.2019

1. Total positions

____________
		% of voting
	% of voting			rights through Total of both Total number of
	rights attached financial/other in % (7.A +			voting rights
	to shares (7.A) instruments		7.B)	of issuer
__ _______________ (7.B.1+7.B.2) __ __
Resulting
situation on
the date on	8,47 %	0,00 %	8,47 %	1 260 000
which threshold
was crossed /
_reached __ __ __ __
Position of
previous
notification
(if_applicable) __ __ __ ___

Details

7. Notified details of the resulting situation:

				____________
A:Voting_rights_attached_to_shares______
				_Numberof_voting_rights _______%of_voting_rights____
	Direct	Indirect	Direct	Indirect
ISIN Code				(Sec 130 BörseG (Sec 133 BörseG (Sec 130 BörseG (Sec 133 BörseG
				___ 2018)__ _2018) __2018)_ 2018)___
				ATMARINOMED6_ __ ________106_666 _______________ __________8,47%
				SUBTOTAL_A__ ____________106_666____________ _____________8,47%_______

|B 1: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 1 BörseG | |2018__________________________________________________________________________| | | | |Number of voting | | | | | | rights that may | | | Type of | | | be | % of voting | | instrument |Expiration Date|Exercise Period|acquired if the | rights | | | | | instrument is | | |_____________|_______________|_______________|____exercised____|______________| |_____________|_______________|_SUBTOTAL_B.1__|_________________|______________|

______________________________________________________________________________

___________
B 2: Financial / Other Instruments pursuant to Sec. 131 para. 1 No. 2 BörseG
2018_____________
Type of	Expiration Exercise		Physical /		Number of		% of voting
instrument	Date	Period	Cash		voting rights		rights
__ _ ___________ Settlement__ ____ ______
__ _ __ SUBTOTALB.2_ __ _

1. Information in relation to the person subject to the notification obligation: Full chain of controlled undertakings through which the voting rights and/or the financial/other instruments are effectively held starting with the ultimate controlling natural person or legal entity:

	____________			Financial/
		Directly	Shares held	other
No.	Name	controlled directly		instruments	Total of
		by No.	(%)	held	both (%)
				directly
	_ __ __ _ _(%)_ ______
1	Republik
	_ Österreich_ _ __ _ ___
	Austria
2	Wirtschaftsservice	1
	_ GmbH__ _ __ _ ______
	aws
3	Fondsmanagement	2
	_ GmbH__ _ __ _ ______
	aws
4	Mittelstandsfonds	3	8,47 %		8,47 %
	Beteiligungs GmbH
	_ &Co_KG_ __ _ __ ______

1. In case of proxy voting Date of general meeting: - Voting rights after general meeting: - is equivalent to - voting rights. 10. Sonstige Kommentare: Die Meldung erfolgt aufgrund der erstmaligen Zulassung gem § 130 Abs 7 BörseG 2018. Korrektur der zuvor gesendeten Meldung, da laut Emittent Kapitalerhöhung eingetragen vor Zustellung des Zulassungsbescheids und somit Anzahl Stimmrechte nach Kapitalerhöhung zu melden sind. Wien am 4.2.2019

end of announcement euro adhoc --------------------------------------------------------------------------------

issuer:	Marinomed Biotech AG
	Veterinärplatz 1
	A-1210 Wien
phone:	0043250774460
FAX:	0043250774493
mail:	office@marinomed.com
WWW:	www.marinomed.com
ISIN:	ATMARINOMED6, AT0000A1WD52

indexes: stockmarkets: Wien language: English

Aussendung übermittelt durch euro adhoc
The European Investor Relations Service